BIO CEO & Investor Conference
Recent Companion Dx Nods a Win for Personalized Medicine
By Michael Harris
Wednesday, February 15, 2012
NEW YORK Appropriately enough on Valentine's Day, there was news of a blossoming hook-up coming out of the BIO CEO & Investor Conference. The marriage of biopharma drugs and medical technology to develop the companion diagnostics market could be primed to deliver smart therapeutics and produce a family of hybrid products that have the capacity to prematurely discover disease, abort its onset or nurse its symptoms.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.